Previous Article | Next Article 
Journal of Clinical Microbiology, October 1998, p. 2893-2899, Vol. 36, No. 10
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Prolonged Replication of a Type 1 Vaccine-Derived
Poliovirus in an Immunodeficient Patient
Olen M.
Kew,1,*
Roland W.
Sutter,2
Baldev K.
Nottay,1
Michael J.
McDonough,1
D. Rebecca
Prevots,3
Linda
Quick,2 and
Mark A.
Pallansch1
Division of Viral and Rickettsial Diseases,
National Center for Infectious Diseases,1 and
Divisions of Eradication of Vaccine-Preventable
Diseases2 and
Epidemiology and
Surveillance,3 National Immunization
Program, Centers for Disease Control and Prevention, Atlanta,
Georgia 30333
Received 11 March 1998/Returned for modification 5 June
1998/Accepted 26 June 1998
VP1 sequences were determined for poliovirus type 1 isolates
obtained over a 189-day period from a poliomyelitis patient with common
variable immunodeficiency syndrome (a defect in antibody formation).
The isolate from the first sample, taken 11 days after onset of
paralysis, contained two poliovirus populations, differing from the
Sabin 1 vaccine strain by ~10%, differing from diverse type 1 wild
polioviruses by 19 to 24%, and differing from each other by 5.5% of
nucleotides. Specimens taken after day 11 appeared to contain only one
major poliovirus population. Evolution of VP1 sequences at synonymous
third-codon positions occurred at an overall rate of ~3.4% per year
over the 189-day period. Assuming this rate to be constant throughout
the period of infection, the infection was calculated to have started
~9.3 years earlier. This estimate is about the time (6.9 years
earlier) the patient received his last oral poliovirus vaccine dose,
approximately 2 years before the diagnosis of immunodeficiency. These
findings may have important implications for the strategy to eliminate
poliovirus immunization after global polio eradication.
*
Corresponding author. Mailing address: Respiratory and
Enteric Viruses Branch, G-10, Division of Viral and Rickettsial
Diseases, National Center for Infectious Diseases, Centers for Disease
Control and Prevention, Atlanta, GA 30333. Phone: (404) 639-3940. Fax: (404) 639-2648. E-mail: omk1{at}cdc.gov.
Journal of Clinical Microbiology, October 1998, p. 2893-2899, Vol. 36, No. 10
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Odoom, J. K., Yunus, Z., Dunn, G., Minor, P. D., Martin, J.
(2008). Changes in Population Dynamics during Long-Term Evolution of Sabin Type 1 Poliovirus in an Immunodeficient Patient. J. Virol.
82: 9179-9190
[Abstract]
[Full Text]
-
Zurbriggen, S., Tobler, K., Abril, C., Diedrich, S., Ackermann, M., Pallansch, M. A., Metzler, A.
(2008). Isolation of Sabin-Like Polioviruses from Wastewater in a Country Using Inactivated Polio Vaccine. Appl. Environ. Microbiol.
74: 5608-5614
[Abstract]
[Full Text]
-
Dedepsidis, E., Kyriakopoulou, Z., Pliaka, V., Kottaridi, C., Bolanaki, E., Levidiotou-Stefanou, S., Komiotis, D., Markoulatos, P.
(2007). Retrospective Characterization of a Vaccine-Derived Poliovirus Type 1 Isolate from Sewage in Greece. Appl. Environ. Microbiol.
73: 6697-6704
[Abstract]
[Full Text]
-
Romanenkova, N. I., Guillot, S., Rozaeva, N. R., Crainic, R., Bichurina, M. A., Delpeyroux, F.
(2006). Use of a Multiple Restriction Fragment Length Polymorphism Method for Detecting Vaccine-Derived Polioviruses in Clinical Samples. J. Clin. Microbiol.
44: 4077-4084
[Abstract]
[Full Text]
-
Macadam, A. J., Ferguson, G., Stone, D. M., Meredith, J., Knowlson, S., Auda, G., Almond, J. W., Minor, P. D.
(2006). Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication.. J. Virol.
80: 8653-8663
[Abstract]
[Full Text]
-
Yakovenko, M. L., Cherkasova, E. A., Rezapkin, G. V., Ivanova, O. E., Ivanov, A. P., Eremeeva, T. P., Baykova, O. Y., Chumakov, K. M., Agol, V. I.
(2006). Antigenic Evolution of Vaccine-Derived Polioviruses: Changes in Individual Epitopes and Relative Stability of the Overall Immunological Properties. J. Virol.
80: 2641-2653
[Abstract]
[Full Text]
-
Yang, C.-F., Chen, H.-Y., Jorba, J., Sun, H.-C., Yang, S.-J., Lee, H.-C., Huang, Y.-C., Lin, T.-Y., Chen, P.-J., Shimizu, H., Nishimura, Y., Utama, A., Pallansch, M., Miyamura, T., Kew, O., Yang, J.-Y.
(2005). Intratypic Recombination among Lineages of Type 1 Vaccine-Derived Poliovirus Emerging during Chronic Infection of an Immunodeficient Patient. J. Virol.
79: 12623-12634
[Abstract]
[Full Text]
-
Arita, M., Zhu, S.-L., Yoshida, H., Yoneyama, T., Miyamura, T., Shimizu, H.
(2005). A Sabin 3-Derived Poliovirus Recombinant Contained a Sequence Homologous with Indigenous Human Enterovirus Species C in the Viral Polymerase Coding Region. J. Virol.
79: 12650-12657
[Abstract]
[Full Text]
-
Laine, P., Savolainen, C., Blomqvist, S., Hovi, T.
(2005). Phylogenetic analysis of human rhinovirus capsid protein VP1 and 2A protease coding sequences confirms shared genus-like relationships with human enteroviruses. J. Gen. Virol.
86: 697-706
[Abstract]
[Full Text]
-
Cherkasova, E. A., Yakovenko, M. L., Rezapkin, G. V., Korotkova, E. A., Ivanova, O. E., Eremeeva, T. P., Krasnoproshina, L. I., Romanenkova, N. I., Rozaeva, N. R., Sirota, L., Agol, V. I., Chumakov, K. M.
(2005). Spread of Vaccine-Derived Poliovirus from a Paralytic Case in an Immunodeficient Child: an Insight into the Natural Evolution of Oral Polio Vaccine. J. Virol.
79: 1062-1070
[Abstract]
[Full Text]
-
Shimizu, H., Thorley, B., Paladin, F. J., Brussen, K. A., Stambos, V., Yuen, L., Utama, A., Tano, Y., Arita, M., Yoshida, H., Yoneyama, T., Benegas, A., Roesel, S., Pallansch, M., Kew, O., Miyamura, T.
(2004). Circulation of Type 1 Vaccine-Derived Poliovirus in the Philippines in 2001. J. Virol.
78: 13512-13521
[Abstract]
[Full Text]
-
Martin, J., Odoom, K., Tuite, G., Dunn, G., Hopewell, N., Cooper, G., Fitzharris, C., Butler, K., Hall, W. W., Minor, P. D.
(2004). Long-Term Excretion of Vaccine-Derived Poliovirus by a Healthy Child. J. Virol.
78: 13839-13847
[Abstract]
[Full Text]
-
Kilpatrick, D. R., Ching, K., Iber, J., Campagnoli, R., Freeman, C. J., Mishrik, N., Liu, H.-M., Pallansch, M. A., Kew, O. M.
(2004). Multiplex PCR Method for Identifying Recombinant Vaccine-Related Polioviruses. J. Clin. Microbiol.
42: 4313-4315
[Abstract]
[Full Text]
-
Blomqvist, S., Savolainen, C., Laine, P., Hirttio, P., Lamminsalo, E., Penttila, E., Joks, S., Roivainen, M., Hovi, T.
(2004). Characterization of a Highly Evolved Vaccine-Derived Poliovirus Type 3 Isolated from Sewage in Estonia. J. Virol.
78: 4876-4883
[Abstract]
[Full Text]
-
Nix, W. A., Berger, M. M., Oberste, M. S., Brooks, B. R., McKenna-Yasek, D. M., Brown, R. H. Jr., Roos, R. P., Pallansch, M. A.
(2004). Failure to detect enterovirus in the spinal cord of ALS patients using a sensitive RT-PCR method. Neurology
62: 1372-1377
[Abstract]
[Full Text]
-
Hovi, T., Lindholm, N., Savolainen, C., Stenvik, M., Burns, C.
(2004). Evolution of wild-type 1 poliovirus in two healthy siblings excreting the virus over a period of 6 months. J. Gen. Virol.
85: 369-377
[Abstract]
[Full Text]
-
Korotkova, E. A., Park, R., Cherkasova, E. A., Lipskaya, G. Y., Chumakov, K. M., Feldman, E. V., Kew, O. M., Agol, V. I.
(2003). Retrospective Analysis of a Local Cessation of Vaccination against Poliomyelitis: a Possible Scenario for the Future. J. Virol.
77: 12460-12465
[Abstract]
[Full Text]
-
Archimbaud, C., Bailly, J.-L., Chambon, M., Tournilhac, O., Travade, P., Peigue-Lafeuille, H.
(2003). Molecular Evidence of Persistent Echovirus 13 Meningoencephalitis in a Patient with Relapsed Lymphoma after an Outbreak of Meningitis in 2000. J. Clin. Microbiol.
41: 4605-4610
[Abstract]
[Full Text]
-
Yang, C.-F., Naguib, T., Yang, S.-J., Nasr, E., Jorba, J., Ahmed, N., Campagnoli, R., van der Avoort, H., Shimizu, H., Yoneyama, T., Miyamura, T., Pallansch, M., Kew, O.
(2003). Circulation of Endemic Type 2 Vaccine-Derived Poliovirus in Egypt from 1983 to 1993. J. Virol.
77: 8366-8377
[Abstract]
[Full Text]
-
Buttinelli, G., Donati, V., Fiore, S., Marturano, J., Plebani, A., Balestri, P., Soresina, A. R., Vivarelli, R., Delpeyroux, F., Martin, J., Fiore, L.
(2003). Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis. J. Gen. Virol.
84: 1215-1221
[Abstract]
[Full Text]
-
Klingel, K., Schnorr, J.-J., Sauter, M., Szalay, G., Kandolf, R.
(2003). {beta}2-Microglobulin-Associated Regulation of Interferon-{gamma} and Virus-Specific Immunoglobulin G Confer Resistance Against the Development of Chronic Coxsackievirus Myocarditis. Am. J. Pathol.
162: 1709-1720
[Abstract]
[Full Text]
-
Halsey, N. A
(2003). Commentary: Poliomyelitis and unnecessary injections. Int J Epidemiol
32: 278-279
[Full Text]
-
Triki, H., Barbouche, M. R., Bahri, O., Bejaoui, M., Dellagi, K.
(2003). Community-Acquired Poliovirus Infection in Children with Primary Immunodeficiencies in Tunisia. J. Clin. Microbiol.
41: 1203-1211
[Abstract]
[Full Text]
-
Minor, P D
(2002). Eradication and cessation of programmes: Vaccination and public health care. Br Med Bull
62: 213-224
[Abstract]
[Full Text]
-
Cherkasova, E. A., Korotkova, E. A., Yakovenko, M. L., Ivanova, O. E., Eremeeva, T. P., Chumakov, K. M., Agol, V. I.
(2002). Long-Term Circulation of Vaccine-Derived Poliovirus That Causes Paralytic Disease. J. Virol.
76: 6791-6799
[Abstract]
[Full Text]
-
Martin, J., Minor, P. D.
(2002). Characterization of CHAT and Cox Type 1 Live-Attenuated Poliovirus Vaccine Strains. J. Virol.
76: 5339-5349
[Abstract]
[Full Text]
-
Lago, P. M., Caceres, V. M, Galindo, M. A, Gary, H. E Jr, Valcarcel, M., Barrios, J., Sarmiento, L., Avalos, I., Bravo, J. A, Palomera, R., Bello, M., Sutter, R. W, Pallansch, M. A, de Quadros, C. A
(2001). Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication. Int J Epidemiol
30: 1029-1034
[Abstract]
[Full Text]
-
Slifka, M. K., Pagarigan, R., Mena, I., Feuer, R., Whitton, J. L.
(2001). Using Recombinant Coxsackievirus B3 To Evaluate the Induction and Protective Efficacy of CD8+ T Cells during Picornavirus Infection. J. Virol.
75: 2377-2387
[Abstract]
[Full Text]
-
Liu, H.-M., Zheng, D.-P., Zhang, L.-B., Oberste, M. S., Pallansch, M. A., Kew, O. M.
(2000). Molecular Evolution of a Type 1 Wild-Vaccine Poliovirus Recombinant during Widespread Circulation in China. J. Virol.
74: 11153-11161
[Abstract]
[Full Text]
-
Guillot, S., Caro, V., Cuervo, N., Korotkova, E., Combiescu, M., Persu, A., Aubert-Combiescu, A., Delpeyroux, F., Crainic, R.
(2000). Natural Genetic Exchanges between Vaccine and Wild Poliovirus Strains in Humans. J. Virol.
74: 8434-8443
[Abstract]
[Full Text]
-
Gavrilin, G. V., Cherkasova, E. A., Lipskaya, G. Y., Kew, O. M., Agol, V. I.
(2000). Evolution of Circulating Wild Poliovirus and of Vaccine-Derived Poliovirus in an Immunodeficient Patient: a Unifying Model. J. Virol.
74: 7381-7390
[Abstract]
[Full Text]
-
Liste, M. B., Natera, I., Suarez, J. A., Pujol, F. H., Liprandi, F., Ludert, J. E.
(2000). Enteric Virus Infections and Diarrhea in Healthy and Human Immunodeficiency Virus-Infected Children. J. Clin. Microbiol.
38: 2873-2877
[Abstract]
[Full Text]
-
Martín, J., Dunn, G., Hull, R., Patel, V., Minor, P. D.
(2000). Evolution of the Sabin Strain of Type 3 Poliovirus in an Immunodeficient Patient during the Entire 637-Day Period of Virus Excretion. J. Virol.
74: 3001-3010
[Abstract]
[Full Text]
-
Bailly, J.-L., Chambon, M., Henquell, C., Icart, J., Peigue-Lafeuille, H.
(2000). Genomic Variations in Echovirus 30 Persistent Isolates Recovered from a Chronically Infected Immunodeficient Child and Comparison with the Reference Strain. J. Clin. Microbiol.
38: 552-557
[Abstract]
[Full Text]
-
Brown, B. A., Oberste, M. S., Alexander, J. P. Jr., Kennett, M. L., Pallansch, M. A.
(1999). Molecular Epidemiology and Evolution of Enterovirus 71 Strains Isolated from 1970 to 1998. J. Virol.
73: 9969-9975
[Abstract]
[Full Text]
-
Mena, I., Perry, C. M., Harkins, S., Rodriguez, F., Gebhard, J., Whitton, J. L.
(1999). The Role of B Lymphocytes in Coxsackievirus B3 Infection. Am. J. Pathol.
155: 1205-1215
[Abstract]
[Full Text]